Anti-parasitic drug can kill the growth of coronavirus in cells within 48 hours finds new study
Researchers have found that an anti-parasitic drug already available around the world can kill the novel coronavirus grown in cell cultures within 48 hours, an advance that may lead to the development and trial of a new clinical therapy for COVID-19.
According to the study, published in the journal Antiviral Research, the drug, Ivermectin, stopped the virus, SARS-CoV-2, from growing in cell culture within 48 hours.
"We found that even a single dose could essentially remove all viral RNA by 48 hours and that even at 24 hours there was a really significant reduction in it," said study co-author Kylie Wagstaff from Monash University in Australia.
The scientists said Ivermectin is an approved antiparasitic drug that has also been shown to be effective in vitro against a broad range of viruses including HIV, Dengue, Influenza and Zika virus.
However, Wagstaff cautioned that the tests conducted in the study were in vitro and that trials needed to be carried out in people.
"Ivermectin is very widely used and seen as a safe drug. We need to figure out now whether the dosage you can use it at in humans will be effective - that's the next step," Wagstaff said.
"In times when we're having a global pandemic and there isn't an approved treatment, if we had a compound that was already available around the world then that might help people sooner," she said.
Although the mechanism by which Ivermectin works on the virus is not known, the scientists said it is likely, based on its action in other viruses, that it works to stop the virus 'dampening down' the host cells' ability to clear it.
"As the virologist who was part of the team who were first to isolate and share SARS-COV2 outside of China in January 2020, I am excited about the prospect of Ivermectin being used as a potential drug against COVID-19," said Leon Caly, study co-author from the Royal Melbourne Hospital in Australia.
The scientists further cautioned that the use of Ivermectin to combat COVID-19 would depend on the results of future pre-clinical testing and ultimately clinical trials.
Updated Date: Apr 06, 2020 07:09:37 IST
COVID-19 treatment: Scientists say brand new flu drug might help in reducing viral load, prevent SARS-CoV-2 transmission
Moderna to begin phase 3 trials in July, Oxford to test Chadox1 on children: All you need to know about COVID-19 vaccines in the works
Hydroxychloroquine sustained dose and PPE can reduce COVID-19 risk in healthcare workers, ICMR study says
Cyclone Nisarga: What to do before, during and after a cyclonic storm to stay safe, secure and healthy
Why social distancing is still the most effective non-pharmaceutical intervention for COVID-19
Studies suggest even mild symptoms of COVID-19 can cause severe damage to lungs, heart and brain
Coronavirus Outbreak Updates: 2,091 people test positive for COVID-19 in Maharashtra today; confirmed cases rise to 54,758 in state
Coronavirus Outbreak Updates: Gujarat BJP MLA Balram Thawani tests positive for COVID-19; 423 new cases reported in state today
Coronavirus Outbreak Updates: Junior assistant in Delhi LG's office tests positive for COVID-19; samples from 40 staff members taken
Coronavirus Outbreak Updates: Film producers' association writes to Uddhav Thackeray requesting resumption of film and TV shoots
Coronavirus Outbreak Updates: Mumbai reports 1,382 new COVID-19 cases; confirmed infections rise to 25,317
Coronavirus Outbreak Updates: With 1,82,143 COVID-19 cases reported till date, India now seventh worst-affected country, says WHO